Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

ONL Therapeutics Inc.

United States 524 South Main Street, 48104-2993, United States

About the sponsor

ONL Therapeutics Inc. focuses on atrophic age-related macular degeneration, with particular attention to geographic atrophy and the preservation of retinal structure and visual function.

  • Atrophic AMD
  • Geographic atrophy
  • Retinal disease

The sponsor’s clinical activity is centered on eye disease research intended to address progressive degeneration of the macula and related loss of central vision.

About Specializations

ONL Therapeutics Inc. runs clinical trials in conditions such as Dry age-related macular degeneration, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Dry age-related macular degeneration

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:XELAFASLATIDE
  • Sponsor:ONL Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.